Clinical trial
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
NCT00366119 · Pacific Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00366119 |
|---|---|
| Title | Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension |
| Official title | Phase 4 Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Ramiprin Tab. in Essential Hypertension |
| Lead sponsor | Pacific Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Essential Hypertension |
| Intervention type | Drug |
| Interventions | Ramipril |
| Enrollment | 86 |
| Start date | Jun 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Aug 18, 2006 |
| Last update posted | Mar 9, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: